HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA methylation
Oncology Reports · 2024
DOI: 10.3892/or.2024.8832 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Xin Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Clinical and Basic Medical Sciences, Shandong First Medical University, Jinan, Shandong 250117, P.R. China. Hauptthemen laut MEDLINE: Homeodomain Proteins, DNA Methylation, Gene Expression Regulation, Neoplastic, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Clinical and Basic Medical Sciences, Shandong First Medical University, Jinan, Shandong 250117, P.R. China.
- Research Center of Basic Medicine, Jinan Central Hospital, Shandong First Medical University, Jinan, Shandong 250013, P.R. China.
Zitieren
APA
Hu, X., Zhang, S., Zhang, X., Liu, H., Diao, Y., & Li, L. (2024). HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA methylation. Oncology Reports. https://doi.org/10.3892/or.2024.8832
Vancouver
Hu X, Zhang S, Zhang X, Liu H, Diao Y, Li L. HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA methylation. Oncology Reports. 2024. doi:10.3892/or.2024.8832
BibTeX
@article{Hu2024,
author = {Hu, Xin and Zhang, Sijia and Zhang, Xiaoyu and Liu, Hongyan and Diao, Yutao and Li, Lianlian},
title = {HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA methylation},
journal = {Oncology Reports},
year = {2024},
doi = {10.3892/or.2024.8832}
}
EUVIMED